Home > Balance Sheet > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Contingent Liabilities

    Back to Balance Sheet
AD     Remove this Ad

BAFNA PHARMACEUTICALS Last 5 Year Contingent Liabilities History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Contingent Liabilities ₹18 Cr₹18 Cr₹10 Cr₹6.17 Cr₹2.00 Cr

What is the latest Contingent Liabilities ratio of BAFNA PHARMACEUTICALS ?

The latest Contingent Liabilities ratio of BAFNA PHARMACEUTICALS is ₹18 Cr based on Mar2025 Standalone results.
Year Contingent Liabilities
Mar2025₹18 Cr
Mar2024₹18 Cr
Mar2023₹10 Cr
Mar2022₹6.17 Cr
Mar2021₹2.00 Cr

How is Contingent Liabilities of BAFNA PHARMACEUTICALS Trending?

Years Contingent Liabilities % Change
Mar2025 ₹18 Cr
-0.06
Mar2024 ₹18 Cr
67.43
Mar2023 ₹10 Cr
69.85
Mar2022 ₹6.17 Cr
208.45
Mar2021 ₹2.00 Cr -

Compare Contingent Liabilities of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹251.9 Cr -8.1% -8.5% 35.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹428,185.0 Cr 3% 9.5% 3.1% Stock Analytics
DIVIS LABORATORIES ₹171,766.0 Cr 1.7% 3.1% 5.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,923.0 Cr 4.7% 11.7% 41.1% Stock Analytics
DR REDDYS LABORATORIES ₹110,081.0 Cr 2.1% 6.7% 11.6% Stock Analytics
CIPLA ₹109,680.0 Cr 1.3% 1.3% -9.4% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

-8.1%

-8.5%

35.6%

SENSEX

-0.3%

-0.1%

8.3%


You may also like the below Video Courses